The Risk for Bleeding in Patients With Atrial Fibrillation From Concomitant Use of Apixaban or Rivaroxaban With Diltiazem Compared With Metoprolol

Authors

Institutions

Publication Details

Journal
Annals of Internal Medicine
Published
2026-02-23
DOI
https://doi.org/10.7326/annals-25-01408
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Risk for Bleeding in Patients With Atrial Fibrillation From Concomitant Use of Apixaban or Rivaroxaban With Diltiazem Compared With Metoprolol

Yacob G. Tedla, Adam Cuker, James D. Lewis
Annals of Internal Medicine
Atrial Fibrillation Management and Outcomes
article

The Risk for Bleeding in Patients With Atrial Fibrillation From Concomitant Use of Apixaban or Rivaroxaban With Diltiazem Compared With Metoprolol

Yacob G. Tedla, Adam Cuker, James D. Lewis
article en

Abstract

No abstract available for this paper.
Annals of Internal Medicine
Vanderbilt University (US), University of Pennsylvania (US)
Zero hunger
Openalex Percentile: Top 50%
Atrial Fibrillation Management and Outcomes
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.